Penumbra (NYSE:PEN) Given "Overweight" Rating at Piper Sandl

Piper Sandler reissued their overweight rating on shares of Penumbra (NYSE:PEN – Free Report) in a report published on Friday, Benzinga reports. Piper Sandler currently has a $290.00 price target on the stock, down from their prior price target of $310.00. A number of other brokerages also recently weighed in on PEN. Morgan Stanley decreased […]

Related Keywords

Canada , United States , Piper Sandler , Johanna Roberts , Jpmorgan Chase Co , Hussman Strategic Advisors Inc , Bessemer Group Inc , Penumbra Inc , Royal Bank , Penumbra Company Profile , Canaccord Genuity Group , Securities Exchange Commission , Capital Management Inc , Morgan Stanley , Free Report , Moderate Buy , Get Free Report , Director Bridgeto Rourke , Exchange Commission , Hussman Strategic Advisors , Penumbra System , Revascularization Device , Penumbra Coil , Penumbra Daily , Penumbra , Nyse Pen , Pen , Medical , Reiterated Rating ,